Stay updated on Dupilumab Efficacy in CRSsNP: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab Efficacy in CRSsNP: Clinical Trial page.

Latest updates to the Dupilumab Efficacy in CRSsNP: Clinical Trial page
- Check2 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2 while the page remains a 403 error.SummaryDifference0.2%

- Check8 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content and navigation. This indicates the record is currently inaccessible due to access restrictions.SummaryDifference18%

- Check51 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, indicating a minor patch-level update with no changes to the study details or page content.SummaryDifference0.0%

- Check65 days agoChange DetectedThe plain language Results Summary, sponsor credit for Sanofi, and the 'Helpful Links Provided by' label were removed from the Study Details page. This results in a leaner page presentation while keeping the essential study information intact.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page now shows revision v3.6.5, replacing v3.6.4. This indicates an internal update without changes to the visible content.SummaryDifference0.0%

Stay in the know with updates to Dupilumab Efficacy in CRSsNP: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab Efficacy in CRSsNP: Clinical Trial page.